The COVID-19 pandemic also negatively impacted the global medicated skin care products market, which decreased sales by more than 2% in 2020.
The global medicated skin care products market report explores the critical analysis of the medicated skin care products industry using key parameters. The report consists of investment strategies, the need for investments in the medicated skin care products industry, and the multiple benefits for investors. Importantly, this report sets out major changes in the global technical regulations for the medicated skin care products industry and how economic and non-economic barriers are helping the market grow. Moreover, the report analyses the global, regional, and country-level historic and forecasted market size. The report also provides a comprehensive analysis of key investment propositions, demand and supply gap, competitors positioning, STAR analysis, SRC analysis, and Tornado analysis. Key technological developments and other analyses include Porter's five forces analysis, PESTEL analysis, value chain analysis, etc.
REPORT ATTRIBUTE | DETAILS |
---|---|
Medicated Skin Care Products Market by Volume |
Yes |
Medicated Skin Care Products Market by Value |
Yes |
Medicated Skin Care Products Market, Tornado Analysis |
Yes |
Medicated Skin Care Products Market, STAR Analysis |
Yes |
Medicated Skin Care Products Market, SRC Analysis |
Yes |
Medicated Skin Care Products Market, Import-Export Data |
Yes (On Demand) |
Medicated Skin Care Products Market Pricing Analysis |
Yes (On Demand) |
Medicated Skin Care Products Market Segment Analysis |
By Ingredient Type (Surfactants, Emulsifiers, Emollients, Rheology Modifiers, and Conditioning Polymers) By Product Type (Cleaners, Toners, Scrubs & Masks, Serums, Moisturizers, Eye Creams, Sun Protection Factor (SPF), and Others) By Application (Acne, Anti-aging, Brightening, Sensitive Skin, Dry Skin, Combination Skin, Oily Skin, Enlarged Pores, and Others) By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Beauty Clinics, Hypermarkets & Supermarkets) |
Medicated Skin Care Products Market, Regional Analysis |
North America (the US and Canada) Europe (Germany, UK, France, Italy, Spain, and the Rest of Europe) Asia Pacific (China, India, Japan, South Korea, South East Asia, and the Rest of Asia Pacific) Latin America (Brazil, Mexico, and the Rest of Latin America) Middle East and Africa (GCC Countries, South Africa, and the Rest of Middle East and Africa) |
Medicated Skin Care Products Market Key Companies |
L'Oreal, Procter & Gamble, Unilever, Colgate-Palmolive Company, The Estee Lauder Inc, Natura & Company, Johnson & Johnson, Beiersdorf AG, and Shiseido Company Limited |
Medicated Skin Care Products Market Competitive Landscape |
Market Share Analysis Competitive Benchmarking Key Players Market Positioning Geographical Presence Analysis Major Strategies Adopted |
North America dominated the global medicated skin care products market in 2021 and is expected to maintain its dominance throughout the forecast period. Consumers in North American nations such as the United States and Canada are willing to pay a premium for a more youthful appearance and brighter, glowing skin. Rising consumer demand for medicated skin care solutions and increased awareness about specific ingredients are expected to drive demand for personalized medicated skin care products. The availability of reputable product producers in North America, including Procter & Gamble and Unilever, and the expansion of retail infrastructure facilities, are anticipated to support the demand for medicated skin care products.
In 2021, the United States dominated the North American medicated skin care products market, and this trend is anticipated to hold throughout the forecast period. Key growth factors for the nation's medicated skin care products market include the rising importance of personalized skin care, raising awareness of the damaging effects of sun exposure on the skin, the popularity of medicated skin care products among men, insufficient sleep and nutrient-deficient diets that contribute to a variety of skin-related problems, and the steady introduction of safe, effective products. Medical skin care products that benefit health and the environment are in high demand in the United States. Moreover, consumers keep up with trends, so various businesses offer products to meet customer demand.
Several well-established companies and recent entrants make up the market for medicated skin care products. Companies have added fresh and cutting-edge medicated skin care products to their product lines to increase the number of consumers. For instance, Shiseido Co. Ltd. announced the release of ULTIMUNE Power Infusing Concentrate III, a new version of the renowned serum ULTIMUNE Power Infusing Concentrate N, in Japan in July 2021. The medicated product will be available in nearly 380 stores across the country and on the Watashi+ beauty website. Similarly, P&G's GoodSkin MD was introduced in CVS Pharmacy's online and offline stores in June 2021. Sunscreen, vitamin C, vitamin B serums, a night cream, a salvage cream, and a cleaner will be among the six medicated skin care products the brand offers.
People are becoming more technologically savvy about the various new skin care products. In addition to aesthetic applications, medical skin care products address acne, pimples, and scars. Moreover, consumers are informed about technological advancements in medicated skin care products. Hence a variety of businesses offer goods to meet consumer demand. For instance, thousands of variations exist on a single face mask product. This gives consumers various options for selecting the product based on their skin type. In addition, market players selling medical skin care products are introducing products with cutting-edge technology. For example, Santinov launched the CICABEL mask using stem cell material and advanced technologies. The stem cells incorporated into the medicated skin care product aid in cell protection, activation, the proliferation of skin epidermal cells, and anagenesis of skin fibrosis.
Manufacturers have been encouraged to release new medicated skin care products due to growing investments in product research and development and the trend toward skincare products made with natural ingredients. For instance, in June 2021, Hale Cosmeceuticals, a reputable medicated skin care product manufacturer in the United States, introduced two natural ingredients for the American market: Date Palm Deep Moisturizer and Natural AZA Cleanser. The significant revenue increase has also been attributed to investments in R&D to create new products and ambitious strategic marketing campaigns by established players. The key players also invest heavily in setting up manufacturing facilities and broadening their worldwide presence, owing to the increasing demand for medicated skin care products on a global scale.
Some major players in the medicated skin care products market are L'Oreal, Procter & Gamble, Unilever, Colgate-Palmolive Company, Estee Lauder Inc, Natura & Company, Johnson & Johnson, Beiersdorf AG, and Shiseido Company Limited.
The rising prevalence and incidence of various skin conditions and the demand for products that maintain, enhance, nourish, prevent, treat, and correct the skin propel the global market growth. The aging population and its susceptibility to skin changes, the exponentially growing demand for improved preventative and maintenance universal health care, and the popularity of corrective and aesthetic care among the young and middle-aged population all provide substantial global market opportunities for medicated skin care products over the forecast period.
The availability of low-quality skin care products on the market and the increased price of some medicated skin care products may be limiting factors for the growth of the global medicated skin care products industry. As copied products are made using different chemicals and cause skin-related issues like rashes and allergies, the high cost of goods impedes market expansion. Excessive skincare use harms the skin and can lead to skin problems.
The supermarkets and hypermarkets segment is expected to maintain its dominance over the forecast period. Supermarkets and hypermarkets provide significant customer benefits, such as greater selection, lower prices, and better exposure to international brands, making them ideal entities for all customers. According to a July 2021 Entrepreneur Handbook, Asda, Sainsbury's, Tesco, and Morrisons supermarkets accounted for 63% of retail and hypermarket sales in the United Kingdom. Supermarkets and hypermarkets are suitable distribution channels for all different types of customers of medicated skincare products as they provide significant benefits to consumers, such as relatively low prices and increased visibility of global brands. The ease and convenience of purchasing such products from hypermarkets and supermarkets are expected to boost segmental growth.
North America will retain the largest medicated skincare product market throughout the forecast period. The growth of the chemical sector in the United States and Canada, both supported by regulatory support, is anticipated to guarantee continuous raw material access to manufacturers of medicated skin care products and, as a result, to be favorable for the market in the region during the projected period. In terms of consumption and production, the United States is one of the major nations influencing the global expansion of medicated cosmetics and skin care products. Numerous government policies support the country's demand for medicated skin care products.
Furthermore, the Asia Pacific region is expected to have the highest revenue share in the global medicated skin care products market during the forecast period. The demand for medicated skin care products is increasing in the region due to the rising population and rapid urbanization and the increase in per capita spending on personal care items in highly developing nations like China, Japan, South Korea, and India. Besides, the increasing availability of low-cost skincare products contributes to the growth of the medicated skin care products market during the forecast period. Moreover, the use of facial care products in China is predominate in the nation's tier-one cities, with growing penetration in the nation's tier-two and tier-three cities, which have been facing a rise in China's growing middle class and the overall usage of medicated skin and personal care products.
Various governmental organizations from all over the world control medicated skin care products. Although the regulatory frameworks in each nation differ, they all aim to ensure the safety and accurate labeling of medicated skin care products in the market. Regulatory regulations from the China Food and Drug Administration (CFDA) prohibit using new unregistered medicated skin care product ingredients. As a result, the use of novel ingredients is constrained globally, which hinders the development of pharmacologically active personal care products. These stringent regulations increase the cost of any new product released onto the market, delay or prohibit the introduction of new products, and may even lead to product recalls. As a result, the introduction of new regulations and modifications to existing regulations may limit the global market.
The global medicated skin care products market is anticipated to grow at a substantial CAGR of 2.5% in the upcoming years. The global medicated skin care products industry is estimated to be worth USD 6978.6 million in 2021 and is expected to be worth USD 8093.03 million by 2028.
Consumer behavior has changed significantly, especially in developing nations like Brazil, China, and India. Increases in income and purchasing power drive global market expansion. This has increased the demand in these countries for personal care ingredients. The general public's awareness of beauty, hygiene, and health have gradually grown. Rural areas in India and China now have easy access to high-end medicated skin and hair care products, previously only available in urban areas. This shift in consumption habits propels the medicated skin care products industry forward. People's shopping behaviors have changed significantly due to the online distribution channel, which provides advantages like doorstep delivery, simple payment options, steep discounts, and the availability of a wide variety of products on a single platform. Due to the growing consumer preference for mobile shopping and the rising internet penetration, major medicated skin care product industry players are increasingly launching e-commerce websites in sizable, lucrative markets.
The growing demand for natural-based active ingredients provides market participants with lucrative opportunities. Consumers from developed nations highly prefer eco-friendly packaging and goods that have received vegan certification. Numerous companies that compete in domestic and global markets produce skin care items using organic ingredients like olive oil, chamomile oil, and cleansers made from coconuts. For instance, PURITO, a South Korean cosmetics company, has announced the February 2020 launch of 'PURITO Centella Green,' a vegan-friendly line of derma-medicated skin care products. This new product line caters to customers with sensitive skin and the growing consumer desire for ethical and environmentally friendly medicated cosmetics.
Global Medicated Skin Care Products Market – By Ingredient Type
Global Medicated Skin Care Products Market – By Product Type
Global Medicated Skin Care Products Market – By Application
Global Medicated Skin Care Products Market – By Distribution Channel
Global Medicated Skin Care Products Market – By Region
The COVID-19 pandemic also negatively impacted the global medicated skin care products market, which decreased sales by more than 2% in 2020.
North America accounted for the most heightened share in the global medicated skin care products market.
The rapidly increasing prevalence and incidence of various skin conditions and the demand for products that maintain, nourish, improve, prevent, treat, and correct the skin are propelling growth in the global medicated skin care products market.
The surfactants segment had a major share in the global market in 2021.
The moisturizers segment had a major share in the global market.
Report Attribute | Details |
---|---|
Market Value in 2021 | USD 6978.6 million |
Market Value in 2028 | USD 8093.03 million |
CAGR | 2.5% |
Benchmarking Year | 2021 |
Past data | 2016 – 2021 |
Forecast period | 2022 – 2028 |